• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚拉各斯地区 COVID-19 患者的血液学指标和凝血特征与疾病严重程度的相关性及其与临床结局的关系。

Haematological indices and coagulation profile as predictors of disease severity and associations with clinical outcome among COVID-19 patients in Lagos, Nigeria.

机构信息

Department of Medicine, College of Medicine University of Lagos; Department of Medicine, Lagos University Teaching Hospital, Idi-Araba, Nigeria.

Department of Haematology and Blood Transfusion, Lagos University Teaching Hospital, Idi-Araba, Nigeria.

出版信息

Ann Afr Med. 2023 Apr-Jun;22(2):204-212. doi: 10.4103/aam.aam_111_22.

DOI:10.4103/aam.aam_111_22
PMID:37026201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10262861/
Abstract

BACKGROUND

This study aims to evaluate the use of haematological indices and coagulation profiles as possible low-cost predictors of disease severity and their associations with clinical outcomes in COVID-19-hospitalized patients in Nigeria.

MATERIALS AND METHODS

We carried out a hospital-based descriptive 3-month observational longitudinal study of 58 COVID-19-positive adult patients admitted at the Lagos University Teaching Hospital, Lagos, Nigeria. We used a structured questionnaire to obtain the participants' relevant sociodemographic and clinical data, including disease severity. Basic haematologic indices, their derivatives, and coagulation profile were obtained from patients' blood samples. Receiver Operating Characteristic (ROC) analysis was used to compare these laboratory-based values with disease severity. A P < 0.05 was considered statistically significant.

RESULTS

The mean age of the patients was 54.4 ± 14.8 years. More than half of the participants were males (55.2%, n = 32) and most had at least one comorbidity (79.3%, n = 46). Significantly higher absolute neutrophil count (ANC), neutrophil-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), lower absolute lymphocyte count (ALC) and lymphocyte-monocyte ratio (LMR) were associated with severe disease (P < 0.05). Patients' hemoglobin concentration (P = 0.04), packed cell volume (P < 0.001), and mean cell hemoglobin concentration (P = 0.03) were also significantly associated with outcome. Receiver operating characteristic (ROC) analysis of disease severity was significant for the ANC, ALC, NLR, LMR, and SII. The coagulation profile did not show any significant associations with disease severity and outcomes in this study.

CONCLUSION

Our findings identified haematological indices as possible low-cost predictors of disease severity in COVID-19 in Nigeria.

摘要

背景

本研究旨在评估血液学指标和凝血谱是否可作为尼日利亚 COVID-19 住院患者疾病严重程度的低成本预测指标,并探讨其与临床结局的关系。

材料与方法

我们进行了一项基于医院的 3 个月描述性纵向研究,纳入了 58 名在尼日利亚拉各斯大学教学医院住院的 COVID-19 阳性成年患者。我们使用结构化问卷获取参与者的相关社会人口学和临床数据,包括疾病严重程度。从患者的血液样本中获得基本的血液学指标、其衍生物和凝血谱。使用受试者工作特征(ROC)分析比较这些实验室值与疾病严重程度的关系。P 值<0.05 为统计学显著。

结果

患者的平均年龄为 54.4±14.8 岁。超过一半的参与者为男性(55.2%,n=32),大多数至少有一种合并症(79.3%,n=46)。中性粒细胞绝对值(ANC)、中性粒细胞与淋巴细胞比值(NLR)、全身性免疫炎症指数(SII)较高,而淋巴细胞绝对值(ALC)和淋巴细胞与单核细胞比值(LMR)较低与严重疾病相关(P<0.05)。患者的血红蛋白浓度(P=0.04)、红细胞压积(P<0.001)和平均红细胞血红蛋白浓度(P=0.03)也与结局显著相关。疾病严重程度的 ROC 分析显示 ANC、ALC、NLR、LMR 和 SII 具有显著预测价值。在本研究中,凝血谱与疾病严重程度和结局无显著相关性。

结论

我们的发现表明,血液学指标可能是尼日利亚 COVID-19 疾病严重程度的低成本预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/6674b66d8be4/AAM-22-204-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/170a5b129cb8/AAM-22-204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/b80e131433af/AAM-22-204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/9a81dd417212/AAM-22-204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/e42c0d1a4b1f/AAM-22-204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/72ad24123789/AAM-22-204-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/e39b8ca97bf7/AAM-22-204-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/6674b66d8be4/AAM-22-204-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/170a5b129cb8/AAM-22-204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/b80e131433af/AAM-22-204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/9a81dd417212/AAM-22-204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/e42c0d1a4b1f/AAM-22-204-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/72ad24123789/AAM-22-204-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/e39b8ca97bf7/AAM-22-204-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9987/10262861/6674b66d8be4/AAM-22-204-g007.jpg

相似文献

1
Haematological indices and coagulation profile as predictors of disease severity and associations with clinical outcome among COVID-19 patients in Lagos, Nigeria.尼日利亚拉各斯地区 COVID-19 患者的血液学指标和凝血特征与疾病严重程度的相关性及其与临床结局的关系。
Ann Afr Med. 2023 Apr-Jun;22(2):204-212. doi: 10.4103/aam.aam_111_22.
2
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can Predict the Severity in COVID-19 Patients from Ethiopia: A Retrospective Study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值可预测埃塞俄比亚新冠肺炎患者的病情严重程度:一项回顾性研究
Int J Gen Med. 2022 Oct 7;15:7701-7708. doi: 10.2147/IJGM.S383558. eCollection 2022.
3
Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.基于全血细胞计数的 COVID-19 患者炎症评分(CBCS)在三级医疗中心。
Altern Ther Health Med. 2021 Jun;27(S1):18-24.
4
Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.评价简单且具有成本效益的免疫血液学标志物,以预测住院严重 COVID-19 患者的结局,重点关注糖尿病 - 印度安得拉邦的回顾性研究。
Diabetes Metab Syndr. 2021 May-Jun;15(3):739-745. doi: 10.1016/j.dsx.2021.03.025. Epub 2021 Mar 29.
5
Hematological Indices Predicting the Severity of Acute Pancreatitis Presenting to the Emergency Department: A Retrospective Analysis.预测急诊科急性胰腺炎严重程度的血液学指标:一项回顾性分析。
Cureus. 2021 Jul 30;13(7):e16752. doi: 10.7759/cureus.16752. eCollection 2021 Jul.
6
Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19.全身免疫炎症指数和中性粒细胞与淋巴细胞比值对重症 COVID-19 患者的预测价值。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221111391. doi: 10.1177/10760296221111391.
7
Associations between Blood Cell Profiles and Primary Open-Angle Glaucoma: A Retrospective Case-Control Study.血细胞谱与原发性开角型青光眼的相关性:一项回顾性病例对照研究。
Ophthalmic Res. 2020;63(4):413-422. doi: 10.1159/000504450. Epub 2020 Feb 4.
8
Comparative analysis of neutrophil to lymphocyte ratio and derived neutrophil to lymphocyte ratio with respect to outcomes of in-hospital coronavirus disease 2019 patients: A retrospective study.关于2019年冠状病毒病住院患者预后的中性粒细胞与淋巴细胞比值及衍生中性粒细胞与淋巴细胞比值的比较分析:一项回顾性研究。
Front Med (Lausanne). 2022 Jul 22;9:951556. doi: 10.3389/fmed.2022.951556. eCollection 2022.
9
Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.免疫、凝血和纤维蛋白溶解过程可能会降低 COVID-19 孕妇发生重症的风险。
Am J Obstet Gynecol. 2021 Apr;224(4):393.e1-393.e25. doi: 10.1016/j.ajog.2020.10.032. Epub 2020 Oct 22.
10
Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.住院 COVID-19 患者的血液学参数和结局:发展中国家的经验。
J Ayub Med Coll Abbottabad. 2021 Jul-Sep;33(3):416-424.

引用本文的文献

1
The predictive role of inflammation indices derived from complete blood count in severe COVID-19 patients: a study from the United Arab Emirates.全血细胞计数衍生的炎症指标在重症新型冠状病毒肺炎患者中的预测作用:来自阿拉伯联合酋长国的一项研究
Front Med (Lausanne). 2025 May 14;12:1565616. doi: 10.3389/fmed.2025.1565616. eCollection 2025.
2
Meta-analysis of the systemic immune-inflammatory index and in-hospital mortality of COVID-19 patients.新型冠状病毒肺炎患者全身免疫炎症指数与院内死亡率的Meta分析
Heliyon. 2023 Dec 8;10(1):e23441. doi: 10.1016/j.heliyon.2023.e23441. eCollection 2024 Jan 15.

本文引用的文献

1
Complete blood count alterations in COVID-19 patients: A narrative review.新型冠状病毒肺炎患者的全血细胞计数改变:一篇叙述性综述。
Biochem Med (Zagreb). 2021 Oct 15;31(3):030501. doi: 10.11613/BM.2021.030501.
2
Routine Hematological Parameters May Be Predictors of COVID-19 Severity.常规血液学参数可能是 COVID-19 严重程度的预测指标。
Front Med (Lausanne). 2021 Jul 16;8:682843. doi: 10.3389/fmed.2021.682843. eCollection 2021.
3
Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
尼日利亚拉各斯 COVID-19 患者合并与不合并高血压的发病率和死亡率结局:一项回顾性队列研究。
Glob Health Res Policy. 2021 Jul 29;6(1):26. doi: 10.1186/s41256-021-00210-6.
4
Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.评估血液学参数作为新冠患者疾病严重程度的指标:来自巴基斯坦的经验。
J Clin Lab Anal. 2021 Jun;35(6):e23809. doi: 10.1002/jcla.23809. Epub 2021 May 24.
5
Priorities for COVID-19 research response and preparedness in low-resource settings.资源匮乏地区针对新冠疫情研究应对与准备的优先事项。
Lancet. 2021 May 22;397(10288):1866-1868. doi: 10.1016/S0140-6736(21)00980-6. Epub 2021 May 6.
6
Outcomes of COVID-19 patients with comorbidities in southwest Nigeria.尼日利亚西南部合并症 COVID-19 患者的结局。
PLoS One. 2021 Mar 15;16(3):e0248281. doi: 10.1371/journal.pone.0248281. eCollection 2021.
7
COVID-19 mortality risk for older men and women.COVID-19 对老年男性和女性的死亡率风险。
BMC Public Health. 2020 Nov 19;20(1):1742. doi: 10.1186/s12889-020-09826-8.
8
Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.新冠病毒肺炎住院患者死亡的血液学预测指标:一项对比研究
Hematology. 2020 Dec;25(1):383-388. doi: 10.1080/16078454.2020.1833435.
9
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.
10
Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.亚洲人群中重症与非重症 COVID-19 患者的实验室特征:系统评价和荟萃分析。
Eur J Med Res. 2020 Aug 3;25(1):30. doi: 10.1186/s40001-020-00432-3.